Our mission at the Myasthenia Gravis Center (MGC) is to provide comprehensive state-of-the-art care to patients with MG through the collaboration of neurologists, surgeons, scientists, rehabilitation medicine therapists, and specialized consultative services.
The MGC is among the few organizations that provides comprehensive diagnostic and therapeutic services, combined with a breadth of research, dedicated to myasthenia gravis. The MGC is part of the partnership consortium of George Washington University School of Medicine & Health Sciences, The GW Medical Faculty Associates, and George Washington University Hospital. Together, the three institutions bring their unique strengths focused on the best care for patients with myasthenia gravis, whether it is in the inpatient or outpatient settings, or the research laboratory.
Every patient referred to the MGC is personally evaluated by the Director, Henry J. Kaminski, MD, at times with the benefit of skilled fellows and residents. After a thorough history, review of previous records, and examination, each patient will then have an investigation tailored to their needs to confirm the diagnosis or identify other conditions. These services include evaluation by the following:
Patients with MG require individual tailoring of therapy to their needs. Therapy will often require high dose prednisone or one of several immunosuppressive therapies. In addition, Dr. Kaminski works closely with colleagues to provide care that many hospitals cannot. The full gamut of specialized treatment options are available to our patients:
National Association of Epilepsy Centers